$SAIC

Science Applications (SAIC) Grew Revenue 6% but Posted a 0.6 Book-to-Bill Ratio. Is the $22B Backlog Enough?

Science Applications International Corporation (SAIC) reported Q2 2027 revenue of $1.88B, up 6.3% YoY, with a book-to-bill ratio of 0.6. Total backlog is $22.1B, including $3.8B funded. Organic revenue growth was 5.3%, and cash flow increased 20%. SAIC raised fiscal 2027 revenue guidance to $7.2B-$7.3B. A post-quarter $740M DHS award may boost next quarter's bookings.

Original reporting
Published Sep 4, 2026, 5:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 6:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Science Applications (SAIC) Grew Revenue 6% but Posted a 0.6 Book-to-Bill Ratio. Is the $22B Backlog Enough? — source image
Decision brief

The 30-second read

$SAICNeutralMed
01

Why it matters

Earnings release provides fresh data for valuation models and short‑term trading decisions.

02

Market read

Earnings and guidance update are primary drivers for SAIC's stock movement.

03

What to watch

Potential impact of upcoming DHS recompete award and future appropriations on bookings.

Relevance 8/10Novelty 8/10Timing: after‑hours release

Background

SAIC reported Q2 FY2027 results with revenue growth, weak bookings, and updated guidance.

Company-level read

Ticker impact

$SAICNeutralMedium confidence
Context

Q2 FY2027 results show 6.3% revenue growth and revised FY2027 revenue guidance to $7.2‑$7.3B.

Expected impact

Potential modest upside if market values higher guidance despite weak book‑to‑bill.

Evidence & confidence

Revenue growth and guidance lift are positive, but low book‑to‑bill and unfunded backlog pose downside risk.

Market effects

Highlights pressure on defense contractors with low book‑to‑bill ratios.

U.S. defense sector may see mixed sentiment.

Limited to investors tracking government contractor earnings.

Counterpoint

Backlog decline and unfunded contracts could outweigh guidance raise, suggesting caution.

Key entities

  • Science Applications International Corporation

    U.S. defense and intelligence contractor.

Related articles

$SAICMedAI 8/10

Science Applications International Corporation Q2 2027 Earnings Call Summary

Science Applications International Corp (SAIC) reported Q2 2027 organic growth of 5%, driven by broad-based strength and improved outlay environment. Management achieved a 90% recompete win rate, securing future growth. Project Orbit, now in implementation, aims to improve efficiency and reduce costs. The company raised FY 2027 guidance for revenue, EBITDA, and EPS, targeting mid-10% margins next year and 11% by 2030. SAIC expects $150M in annual savings from Project Orbit by 2030, with two-thir

$SAICMed

Markets News, Aug. 31, 2026: Major Stock Indexes Post Gains for August Despite Falling Monday Amid Rising Oil Prices

Major indexes fell Monday due to rising oil prices but posted gains for August. Marvell (MRVL) and Amazon (AMZN) shares dropped amid legal issues. Tesla (TSLA) and Nvidia (NVDA) shares rose. SAIC (SAIC) shares surged on strong Q2 results and raised guidance. Tim Cook stepped down as Apple (AAPL) CEO. Broadcom (AVGO) earnings expected Wednesday. Bitcoin (BTC) price near $79,000. Strategy (MSTR) bought 4,603 bitcoins.

$SAICHighAI 8/10

Why SAIC (SAIC) Stock Is Trading Up Today

SAIC's stock rose 5.5% after Q2 CY2026 results beat expectations, with revenue up 6.3% YoY to $1.88B, adjusted EPS at $3.01, and adjusted EBITDA at $193M. The company raised full-year guidance across key metrics. SAIC's shares have gained 31.2% YTD, reaching a 52-week high of $132.75.

$SAICHighAI 9/10

Why SAIC Stock Is Rising Today

SAIC's stock rose 3.2% after reporting Q2 2027 revenue of $1.88B, beating estimates of $1.76B, and adjusted EPS of $3.01, surpassing expectations of $2.31. The company also raised its 2027 revenue and EPS guidance, citing improved performance.